Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tdap (BOOSTRIX) in Pregnant Women in Mali
NCT03589768Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jan 2019
- Primary completion
- Jul 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of acellular pertussis vaccine in pertussis, Tetanus, diphtheria, sponsored by National Institute of Allergy and Infectious Diseases. Started Jan 2019; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
pertussisTetanusdiphtheria
Beyond the preview
Go deeper on NCT03589768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03589768.